Obstetrics & Gynecology

News and Events

Programs and providers of Obstetrics and Gynecology at Weill Cornell Medicine are often the focus of news stories and features appearing in major national media. We invite you to review some stories that typify the breakthrough accomplishments of our remarkable team and highlight the impact our care has had on patient’s lives.

Message to Weill Cornell Medicine Community About Agreement with the U.S. Attorney’s Office

WCM placeholder

Cornell University President Michael I. Kotlikoff and Dr. Robert A. Harrington, Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, sent the following message on July 27 to the Weill Cornell Medicine community.

Dear Weill Cornell Medicine Community,

We are writing to let you know that we have resolved an investigation by the United States Attorney’s Office into former faculty member Darius Paduch’s gross misconduct at Weill Cornell Medicine. The agreement, which was publicly announced just minutes ago, concludes the government’s investigation into this matter, which included Paduch’s 2024 criminal conviction and sentencing.

This resolution is a significant step forward for us in addressing our former faculty member’s misconduct, which represented a profound betrayal of our mission and the trust that patients place in physicians and medical institutions. No patient should ever experience abuse by a clinician. 

Weill Cornell Medicine is a safer organization today than it was when these events occurred. As the U.S. Attorney has acknowledged, we have already implemented significant reforms to enhance patient safety and prevent future misconduct. These include:

Pioneering Physician-Scientist Dr. Julianne Imperato-McGinley Reflects on Her Career Successes

Dr. Imperato-McGinley

Video of Weill Cornell Medicine Honors Dr. Julianne Imperato-McGinley

A 2023 video honors Dr. Julianne Imperato-McGinley's storied career.

As a new endocrinology fellow at what is now Weill Cornell Medicine in the early 1970s, Dr. Julianne Imperato-McGinley hit a wall.

Her first assignment was to write a grant proposal, something she had never done. Over many months, she agonized over every word, tossing many revisions in the trash. Finally, Dr. Imperato-McGinley told her chief she simply couldn’t do it, that he’d picked the wrong person for the job. But he had discovered her almost-daily versions of the document in the wastebasket, fishing them out. “How about sending your version 23?” he asked with a wry smile.

Dr. Imperato-McGinley

Dr. Imperato-McGinley as an endocrinology fellow at Weill Cornell in 1972.

Mapping Human Bone Marrow Yields New Tool, Insights on Blood Cancer

cells stained blue, green and magenta

Weill Cornell Medicine investigators have developed a new AI-based method to assess patients with a form of blood cancer called myelodysplastic neoplasms. The method, published June 30 in Leukemia, compares the physical locations and morphometric (size and shape) characteristics of every hematopoietic cell in the patient’s bone marrow sample with those in healthy bone marrow, to generate a score that reflects disease severity.

Myelodysplastic neoplasms (MDS) is a form of blood cancer that usually affects older adults. About one-third of patients progress to a more aggressive cancer called acute myeloid leukemia. MDS patients must undergo frequent biopsies to identify signs of remission or worsening disease. 

headshot of a man

Dr. Sanjay Patel

Contact Us